Overcoming Therapeutic Inertia as the Achilles' Heel for Improving Suboptimal Diabetes Care: An Integrative Review.
Journal Information
Full Title: Endocrinol Metab (Seoul)
Abbreviation: Endocrinol Metab (Seoul)
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Subject Category: Endocrinology
Available in Europe PMC: Yes
Available in PMC: Yes
PDF Available: No
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"CONFLICTS OF INTEREST: Kamlesh Khunti chairs the American Diabetes Association Overcoming Therapeutic Inertia initiative. Kamlesh Khunti has acted as a consultant, speaker, or received grants for investigator-initiated studies from Astra Zeneca, Bayer, Novartis, Novo Nordisk, Sanofi-Aventis, Lilly and Merck Sharp & Dohme, Boehringer Ingelheim, Oramed Pharmaceuticals, and Applied Therapeutics. No potential conflict of interest relevant to this article was reported by Boon-How Chew, Barakatun-Nisak Mohd-Yusof, and Pauline Siew Mei Lai."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025